Life Sciences

BACKGROUND

Life expectancy is increasing, bringing with it new challenges for pharmaceutical companies.

Between digitisation and genetic research, industry players must innovate in a highly competitive environment.

1.8 billion people will be over 65 in 2058 versus 700 million currently.

The global pharmaceutical market will exceed 1,500 billion dollars within the next five years.

THE CHALLENGES

The sector’s main drivers.

10 000

Categories of medical devices according to the World Organisation, i.e. between 90,000 and 1.5 million different products.

€40 BN

Biotech sector turnover in 2030.

13.6 YEARS

Average development time for a therapeutic drug between the first patent filing and its sales authorisation.

$14.6 BN

were invested in e-health companies in 2018.

ABYLSEN’S
SECTORS OF INTERVENTION

  • Process Engineering
  • Project Engineering (from basic design to Commissioning & Validation)
  • Civil Engineering
  • Qualification & Validation
  • Procurement
  • Automation – IS
  • Maintenance –Equipment reliability
  • Optimisation Process
  • Electricity – automation…
  • CAPA methods – Deviation
  • Quality Assurance Ops – CAPA – Deviation
  • Purchasing
  • Logistics
  • Quality control
  • Health, Safety and the Environment
  • Formulation development
  • Medical devices
  • Data Integrity

Nos cases studies

OUR PROFESSIONAL EXPERTISE

At Abylsen, we move forward with passion and efficiency to develop ingenious solutions to our clients’ operational challenges and meet their performance requirements.

JOIN THE ADVENTURE

We are constantly looking for the best talent to strengthen our Business Expertise.
Evolving within the Abylsen Group means benefiting from a changing and empowering environment.
This freedom is the guarantee for each employee to give their best and to thrive in their projects, their career and within their own team.

Would you like to join the Abylsen adventure?